We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA. Teva Pharmaceutical ...
Teva Pharmaceutical Industries Ltd. announced its plan to issue $2 billion in senior notes through its finance subsidiaries, specifically Teva Finance II, III, and IV, which will offer both EUR- and ...
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. The ...
The Teva Pharmaceutical Finance Co. LLC-Bond has a maturity date of 2/1/2026 and offers a coupon of 0.2500%. The payment of the coupon will take place 2,0 times per biannual on the 01.08.. The Teva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results